Last reviewed · How we verify

NCT06155071

Effects of 8 Week Plyometric Training on Physical Fitness and Technical Skills of Domestic Cricket Players

Completed NA Last updated 19 January 2024
What this trial tests

NA trial testing Plyometric Training in Physical Fitness in 22 participants. Completed in 10 January 2024.

Timeline
14 August 2023
Primary endpoint
30 December 2023
10 January 2024

Quick facts

Lead sponsorRiphah International University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment22
Start date14 August 2023
Primary completion30 December 2023
Estimated completion10 January 2024
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Riphah International University

Who can join

Adults 15 to 25, any sex, with Physical Fitness or Technical Skills. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to find the effectiveness of Plyometric training on Physical fitness and Technical skills of Domestic Cricket players. Players would be taken from District Gujrat and a well designed Plyometric training plan will be implied on them for 8 weeks. After the time span the results would be compared to check the effectiveness of the training plan.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Plyometric Training

Trials testing the same drug.

Other recruiting trials for Physical Fitness

Currently open trials in the same condition.

Other Riphah International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06155071.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing